Aclarion, Inc. (NASDAQ:ACONW) Sees Significant Decline in Short Interest

Aclarion, Inc. (NASDAQ:ACONW) was the recipient of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 69,875 shares, a decrease of 69.9% from the August 15th total of 231,797 shares. Based on an average trading volume of 8,378 shares, the days-to-cover ratio is presently 8.3 days.

Aclarion Stock Up 9.0%

ACONW traded up $0.00 on Friday, reaching $0.03. The stock had a trading volume of 241 shares, compared to its average volume of 21,678. The business’s 50-day moving average price is $0.03 and its two-hundred day moving average price is $0.03. Aclarion has a 12-month low of $0.02 and a 12-month high of $0.23.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.